Suppr超能文献

川西獐牙菜(龙胆科)的从头测序转录组以鉴定参与活性成分生物合成的基因。

De novo sequencing transcriptome of endemic Gentiana straminea (Gentianaceae) to identify genes involved in the biosynthesis of active ingredients.

作者信息

Zhou Dangwei, Gao Shan, Wang Huan, Lei Tianxiang, Shen Jianwei, Gao Jie, Chen Shilong, Yin Jia, Liu Jianquan

机构信息

Key Laboratory of Adaptation and Evolution of Plateau Biota (AEPB), Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, Qinghai, PR China; University of Chinese Academy of Sciences, Beijing 100093, PR China.

College of Life Sciences, Nankai University, Tianjin 300071, PR China.

出版信息

Gene. 2016 Jan 1;575(1):160-70. doi: 10.1016/j.gene.2015.08.055. Epub 2015 Sep 8.

Abstract

Gentiana straminea is a popular Tibetan medicine that has been used for thousands of years in China to treat various diseases and conditions. Although it has multiple pharmaceutical purposes and important economic plant resource in China, transcriptome and molecular base still known limited. In flowering season, samples were collected from different tissues, using the NGS Illumina. Solexa platform, about 58.85 million sequencing reads were generated and assembled de novo, yielding 78,764 high quality unigenes with an average length of 1090bp. Gene Ontology (GO), KEGG pathway mapping showed that 49,033 of these were identified as putative homologs of annotated sequences in the protein databases. Among them, candidate genes associated with iridoid, flavonoid and anthocyanin were identified. Further the key enzymes involved to iridoid and flavonoid synthesis pathway were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) on different tissues, the flower and root had the higher expression than leaves. In addition, 7591 SSR markers were identified from the unigenes of the G. straminea transcriptome. The foundation of G. straminea provided the important resource for facilitating to study molecular and functional genomics of it and related this species on the Qinghai-Tibet Plateau.

摘要

麻花艽是一种著名的藏药,在中国已有数千年用于治疗各种疾病和病症的历史。尽管它具有多种药用价值且是中国重要的经济植物资源,但其转录组和分子基础仍所知有限。在开花季节,从不同组织采集样本,使用NGS Illumina.Solexa平台,产生了约5885万个测序读数并进行了从头组装,得到78764个高质量单基因,平均长度为1090bp。基因本体论(GO)、KEGG通路映射显示其中49033个被鉴定为蛋白质数据库中注释序列的假定同源物。其中,鉴定出了与环烯醚萜、黄酮类化合物和花青素相关的候选基因。进一步通过对不同组织(花和根)进行实时定量聚合酶链反应(qRT-PCR)分析了参与环烯醚萜和黄酮类化合物合成途径的关键酶,花和根中的表达高于叶。此外,从麻花艽转录组的单基因中鉴定出7591个SSR标记。麻花艽的基础研究为促进其分子和功能基因组学以及青藏高原上该物种及相关物种的研究提供了重要资源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验